8 × 15k human mirna-specific microarray Search Results


90
Agilent technologies 8 × 15 k human mirna-specific microarray platform
8 × 15 K Human Mirna Specific Microarray Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8 × 15 k human mirna-specific microarray platform/product/Agilent technologies
Average 90 stars, based on 1 article reviews
8 × 15 k human mirna-specific microarray platform - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Phalanx Biotech human mirna onearray ® mirna profiling chip
A. A schematic representation of the procedure for <t>miRNA</t> selection. Differential expressions of miRNAs in osthole-treated cells versus vehicle-treated cells were analyzed with a <t>OneArray</t> ® miRNA profiling chip. B. Treatment of Du145 cells with osthole for 6 h. miR-146a, miR-22-3p, and miR-23a-3p expressions were detected by a quantitative PCR. C. Upper panel, Du145 cells were transfected with an miR-23a-3p mimic or mimic control for 24 h followed by osthole (60 μM) treatment for an additional 24 h. E-cadherin expression levels were determined by a Western blot analysis. Quantitative E-cadherin protein levels were adjusted to the β-actin protein level. Lower panel, Relative luciferase activities of DU145 cells co-transfected with an E-cadherin luciferase 3′UTR reporter vector and miR-23a-3p mimic or mimic control for 24 h. Values are presented as the mean ± SE of three independent experiments. * p < 0.05, compared to the control groups. D. DU145 cells were transfected with an miR-23a-3p mimic or mimic control for 24 h followed by osthole (60 μM) treatment for an additional 24 h. The cell-invasion ability was determined by a Matrigel invasion assay. Values are presented as the mean ± SE of three independent experiments. Data were analyzed using a one-way ANOVA with Tukey's post-hoc tests at 95% confidence intervals; different letters represent different levels of significance. E. DU145 cells were transfected with either an miR-23a-3p inhibitor or a negative control. The cell-invasion ability was determined by a Matrigel invasion assay. Values are presented as the mean ± SE of three independent experiments. * p < 0.05, compared to the control groups. F. PC3 or DU145 cells were treated with TGF-β for 6, 12, or 24 h. Expression levels of E-cadherin and miR-23a-3p were determined by Western blotting (upper panel) and a quantitative PCR (lower panel), respectively. Quantitative E-cadherin protein levels were adjusted to the β-actin protein level.
Human Mirna Onearray ® Mirna Profiling Chip, supplied by Phalanx Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human mirna onearray ® mirna profiling chip/product/Phalanx Biotech
Average 90 stars, based on 1 article reviews
human mirna onearray ® mirna profiling chip - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Tecan Systems powerscanner
A. A schematic representation of the procedure for <t>miRNA</t> selection. Differential expressions of miRNAs in osthole-treated cells versus vehicle-treated cells were analyzed with a <t>OneArray</t> ® miRNA profiling chip. B. Treatment of Du145 cells with osthole for 6 h. miR-146a, miR-22-3p, and miR-23a-3p expressions were detected by a quantitative PCR. C. Upper panel, Du145 cells were transfected with an miR-23a-3p mimic or mimic control for 24 h followed by osthole (60 μM) treatment for an additional 24 h. E-cadherin expression levels were determined by a Western blot analysis. Quantitative E-cadherin protein levels were adjusted to the β-actin protein level. Lower panel, Relative luciferase activities of DU145 cells co-transfected with an E-cadherin luciferase 3′UTR reporter vector and miR-23a-3p mimic or mimic control for 24 h. Values are presented as the mean ± SE of three independent experiments. * p < 0.05, compared to the control groups. D. DU145 cells were transfected with an miR-23a-3p mimic or mimic control for 24 h followed by osthole (60 μM) treatment for an additional 24 h. The cell-invasion ability was determined by a Matrigel invasion assay. Values are presented as the mean ± SE of three independent experiments. Data were analyzed using a one-way ANOVA with Tukey's post-hoc tests at 95% confidence intervals; different letters represent different levels of significance. E. DU145 cells were transfected with either an miR-23a-3p inhibitor or a negative control. The cell-invasion ability was determined by a Matrigel invasion assay. Values are presented as the mean ± SE of three independent experiments. * p < 0.05, compared to the control groups. F. PC3 or DU145 cells were treated with TGF-β for 6, 12, or 24 h. Expression levels of E-cadherin and miR-23a-3p were determined by Western blotting (upper panel) and a quantitative PCR (lower panel), respectively. Quantitative E-cadherin protein levels were adjusted to the β-actin protein level.
Powerscanner, supplied by Tecan Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/powerscanner/product/Tecan Systems
Average 90 stars, based on 1 article reviews
powerscanner - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agilent technologies microarray chip
Candidate reference miRNAs selected from <t> microarray </t> analysis. <xref ref-type= † " width="250" height="auto" />
Microarray Chip, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray chip/product/Agilent technologies
Average 90 stars, based on 1 article reviews
microarray chip - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agilent technologies 8 × 15 k human mirna-specific microarray v2 platform
Candidate reference miRNAs selected from <t> microarray </t> analysis. <xref ref-type= † " width="250" height="auto" />
8 × 15 K Human Mirna Specific Microarray V2 Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8 × 15 k human mirna-specific microarray v2 platform/product/Agilent technologies
Average 90 stars, based on 1 article reviews
8 × 15 k human mirna-specific microarray v2 platform - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agilent technologies 8×15k human mirna-specific microarray
Candidate reference miRNAs selected from <t> microarray </t> analysis. <xref ref-type= † " width="250" height="auto" />
8×15k Human Mirna Specific Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8×15k human mirna-specific microarray/product/Agilent technologies
Average 90 stars, based on 1 article reviews
8×15k human mirna-specific microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agilent technologies microrna (mirna) expression
Candidate reference miRNAs selected from <t> microarray </t> analysis. <xref ref-type= † " width="250" height="auto" />
Microrna (Mirna) Expression, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microrna (mirna) expression/product/Agilent technologies
Average 90 stars, based on 1 article reviews
microrna (mirna) expression - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agilent technologies 8 × 15k human mirna-specific microarray
Candidate reference miRNAs selected from <t> microarray </t> analysis. <xref ref-type= † " width="250" height="auto" />
8 × 15k Human Mirna Specific Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8 × 15k human mirna-specific microarray/product/Agilent technologies
Average 90 stars, based on 1 article reviews
8 × 15k human mirna-specific microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agilent technologies 8 x 15k human mirna-specific microarrays
Candidate reference miRNAs selected from <t> microarray </t> analysis. <xref ref-type= † " width="250" height="auto" />
8 X 15k Human Mirna Specific Microarrays, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8 x 15k human mirna-specific microarrays/product/Agilent technologies
Average 90 stars, based on 1 article reviews
8 x 15k human mirna-specific microarrays - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agilent technologies human mirna microarray rel12.0
Candidate reference miRNAs selected from <t> microarray </t> analysis. <xref ref-type= † " width="250" height="auto" />
Human Mirna Microarray Rel12.0, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human mirna microarray rel12.0/product/Agilent technologies
Average 90 stars, based on 1 article reviews
human mirna microarray rel12.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agilent technologies 8x15 k human mirna-specific microarray
Summary of the 6 types of molecular data and their platforms used for this study.
8x15 K Human Mirna Specific Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8x15 k human mirna-specific microarray/product/Agilent technologies
Average 90 stars, based on 1 article reviews
8x15 k human mirna-specific microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agilent technologies 8 × 15 k human mirna-specific platforms
Summary of the 6 types of molecular data and their platforms used for this study.
8 × 15 K Human Mirna Specific Platforms, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8 × 15 k human mirna-specific platforms/product/Agilent technologies
Average 90 stars, based on 1 article reviews
8 × 15 k human mirna-specific platforms - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


A. A schematic representation of the procedure for miRNA selection. Differential expressions of miRNAs in osthole-treated cells versus vehicle-treated cells were analyzed with a OneArray ® miRNA profiling chip. B. Treatment of Du145 cells with osthole for 6 h. miR-146a, miR-22-3p, and miR-23a-3p expressions were detected by a quantitative PCR. C. Upper panel, Du145 cells were transfected with an miR-23a-3p mimic or mimic control for 24 h followed by osthole (60 μM) treatment for an additional 24 h. E-cadherin expression levels were determined by a Western blot analysis. Quantitative E-cadherin protein levels were adjusted to the β-actin protein level. Lower panel, Relative luciferase activities of DU145 cells co-transfected with an E-cadherin luciferase 3′UTR reporter vector and miR-23a-3p mimic or mimic control for 24 h. Values are presented as the mean ± SE of three independent experiments. * p < 0.05, compared to the control groups. D. DU145 cells were transfected with an miR-23a-3p mimic or mimic control for 24 h followed by osthole (60 μM) treatment for an additional 24 h. The cell-invasion ability was determined by a Matrigel invasion assay. Values are presented as the mean ± SE of three independent experiments. Data were analyzed using a one-way ANOVA with Tukey's post-hoc tests at 95% confidence intervals; different letters represent different levels of significance. E. DU145 cells were transfected with either an miR-23a-3p inhibitor or a negative control. The cell-invasion ability was determined by a Matrigel invasion assay. Values are presented as the mean ± SE of three independent experiments. * p < 0.05, compared to the control groups. F. PC3 or DU145 cells were treated with TGF-β for 6, 12, or 24 h. Expression levels of E-cadherin and miR-23a-3p were determined by Western blotting (upper panel) and a quantitative PCR (lower panel), respectively. Quantitative E-cadherin protein levels were adjusted to the β-actin protein level.

Journal: Oncotarget

Article Title: By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer

doi:

Figure Lengend Snippet: A. A schematic representation of the procedure for miRNA selection. Differential expressions of miRNAs in osthole-treated cells versus vehicle-treated cells were analyzed with a OneArray ® miRNA profiling chip. B. Treatment of Du145 cells with osthole for 6 h. miR-146a, miR-22-3p, and miR-23a-3p expressions were detected by a quantitative PCR. C. Upper panel, Du145 cells were transfected with an miR-23a-3p mimic or mimic control for 24 h followed by osthole (60 μM) treatment for an additional 24 h. E-cadherin expression levels were determined by a Western blot analysis. Quantitative E-cadherin protein levels were adjusted to the β-actin protein level. Lower panel, Relative luciferase activities of DU145 cells co-transfected with an E-cadherin luciferase 3′UTR reporter vector and miR-23a-3p mimic or mimic control for 24 h. Values are presented as the mean ± SE of three independent experiments. * p < 0.05, compared to the control groups. D. DU145 cells were transfected with an miR-23a-3p mimic or mimic control for 24 h followed by osthole (60 μM) treatment for an additional 24 h. The cell-invasion ability was determined by a Matrigel invasion assay. Values are presented as the mean ± SE of three independent experiments. Data were analyzed using a one-way ANOVA with Tukey's post-hoc tests at 95% confidence intervals; different letters represent different levels of significance. E. DU145 cells were transfected with either an miR-23a-3p inhibitor or a negative control. The cell-invasion ability was determined by a Matrigel invasion assay. Values are presented as the mean ± SE of three independent experiments. * p < 0.05, compared to the control groups. F. PC3 or DU145 cells were treated with TGF-β for 6, 12, or 24 h. Expression levels of E-cadherin and miR-23a-3p were determined by Western blotting (upper panel) and a quantitative PCR (lower panel), respectively. Quantitative E-cadherin protein levels were adjusted to the β-actin protein level.

Article Snippet: To identify which miRNAs are regulated by osthole, a high-throughput and specific miRNA microarray (human miRNA OneArray ® miRNA profiling chip) using Du145 cells after osthole treatment was conducted by the Phalanx Biotech Group (Hsinchu, Taiwan).

Techniques: Selection, Real-time Polymerase Chain Reaction, Transfection, Expressing, Western Blot, Luciferase, Plasmid Preparation, Invasion Assay, Negative Control

Candidate reference miRNAs selected from  microarray  analysis. <xref ref-type= † " width="100%" height="100%">

Journal: PLoS ONE

Article Title: Reference miRNAs for miRNAome Analysis of Urothelial Carcinomas

doi: 10.1371/journal.pone.0039309

Figure Lengend Snippet: Candidate reference miRNAs selected from microarray analysis.

Article Snippet: Based on the total of 723 human miRNA species located on the Agilent microarray chip according to the miRBase version 10.1, we identified 101 miRNAs that were flagged as “present” in all of the examined groups ( ).

Techniques: Microarray

Summary of the 6 types of molecular data and their platforms used for this study.

Journal: PLoS ONE

Article Title: Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients

doi: 10.1371/journal.pone.0154313

Figure Lengend Snippet: Summary of the 6 types of molecular data and their platforms used for this study.

Article Snippet: miRNA , Agilent 8X15 k human miRNA-specific microarray , 437 , 43/394 , 534 , 1 , 1.

Techniques: Mutagenesis, Genome Wide, DNA Sequencing, Expressing, DNA Methylation Assay, Microarray